AF may be detected w reliable monitoring device wearable continuous or loop recording devices implantable loop recorders pacemakers defibrillators and confirmed by physician review Smartphones smartwatches can discriminate AF vs NSR but are not reliable e

By rray, 26 January, 2024
Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> Hindricks G, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. <i>Eur Heart J.</i> 2021 Feb 1;42(5):373-498. <a href=https://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehaa612/33799442/ehaa612.pdf><u>Free, full-text PDF</u></a>
Detail Type
Text
Detail Text
If monitoring device shows AF perform 12 lead ECG 1
If no AF on 12 lead diagnose subclinical AF If AF on 12 lead treat as clinical AF 1
Treat modifiable stroke risk factors 1
Provide ongoing monitoring for progression to clinical AF and change in stroke risk
Patient Type Detail Header (Long)
AF may be detected w/ reliable monitoring device (wearable continuous or loop-recording devices, implantable loop recorders, pacemakers/defibrillators) and confirmed by physician review. Smartphones/smartwatches can discriminate AF vs. NSR but are not reliable enough to establish AF dx. Monitoring for AF may be appropriate in pts w/ cryptogenic stroke.